Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2008 by French National Agency for Research on AIDS and Viral Hepatitis.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Schering-Plough
Rennes University Hospital
Information provided by:
French National Agency for Research on AIDS and Viral Hepatitis
ClinicalTrials.gov Identifier:
NCT00323804
First received: May 9, 2006
Last updated: March 18, 2008
Last verified: March 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given